FERRARONI, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 10.628
EU - Europa 5.092
AS - Asia 4.218
SA - Sud America 660
Continente sconosciuto - Info sul continente non disponibili 170
AF - Africa 140
OC - Oceania 60
Totale 20.968
Nazione #
US - Stati Uniti d'America 10.432
RU - Federazione Russa 1.614
IT - Italia 1.280
SG - Singapore 1.177
CN - Cina 1.054
PL - Polonia 607
BR - Brasile 527
VN - Vietnam 511
HK - Hong Kong 470
IE - Irlanda 399
KR - Corea 361
SE - Svezia 343
DE - Germania 184
BD - Bangladesh 182
FR - Francia 170
IN - India 170
CA - Canada 128
FI - Finlandia 125
GB - Regno Unito 120
UA - Ucraina 109
AU - Australia 58
AR - Argentina 52
ID - Indonesia 49
JP - Giappone 48
JO - Giordania 46
ES - Italia 35
TR - Turchia 35
NL - Olanda 32
CO - Colombia 27
CI - Costa d'Avorio 24
MX - Messico 24
NG - Nigeria 24
IQ - Iraq 22
ZA - Sudafrica 22
CH - Svizzera 20
BE - Belgio 19
EC - Ecuador 16
CR - Costa Rica 12
EG - Egitto 12
MA - Marocco 12
SA - Arabia Saudita 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
PY - Paraguay 11
BJ - Benin 10
PK - Pakistan 10
KE - Kenya 9
MY - Malesia 8
AZ - Azerbaigian 7
CL - Cile 7
PT - Portogallo 7
PH - Filippine 6
SN - Senegal 6
DZ - Algeria 5
GT - Guatemala 5
TN - Tunisia 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
JM - Giamaica 4
LB - Libano 4
NI - Nicaragua 4
NP - Nepal 4
RO - Romania 4
RS - Serbia 4
SC - Seychelles 4
TH - Thailandia 4
AL - Albania 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KG - Kirghizistan 3
LT - Lituania 3
MU - Mauritius 3
PA - Panama 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BG - Bulgaria 2
BO - Bolivia 2
BZ - Belize 2
HU - Ungheria 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
NZ - Nuova Zelanda 2
OM - Oman 2
PE - Perù 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
Totale 20.791
Città #
Santa Clara 1.988
Ashburn 1.379
Singapore 853
Fairfield 836
Warsaw 604
San Jose 413
Woodbridge 401
Dublin 397
Hong Kong 383
Seattle 368
Seoul 359
Cambridge 353
Chandler 337
Houston 321
Wilmington 275
Hefei 266
Milan 249
Council Bluffs 203
Beijing 199
Ann Arbor 162
Dallas 161
Jacksonville 158
Los Angeles 158
Ho Chi Minh City 143
Altamura 138
The Dalles 138
Florence 137
Lawrence 132
New York 129
Lauterbourg 121
Rome 116
Princeton 108
Mumbai 102
Buffalo 89
Hanoi 87
Dong Ket 82
Boston 80
Boardman 77
Moscow 68
Melbourne 56
Kent 55
Phoenix 53
San Diego 50
São Paulo 47
Chicago 46
Tokyo 45
Medford 41
Helsinki 38
Toronto 34
Turin 33
Clifton 30
Jakarta 30
Washington 30
Munich 27
Shanghai 26
Bologna 25
Da Nang 25
Naples 25
Abidjan 23
Abuja 23
Paris 23
Haiphong 22
Norwalk 22
Montreal 21
Orem 21
Atlanta 20
Barcelona 20
Tampa 19
Brussels 18
Frankfurt am Main 18
San Francisco 17
Bern 16
Guangzhou 16
Andover 15
Falls Church 15
Miano 15
Redondo Beach 15
Chennai 14
Hillsboro 14
Izmir 14
Bogotá 13
Denver 13
Palermo 13
Amsterdam 12
Bari 12
Bengaluru 12
Columbus 12
London 12
Yubileyny 12
Brooklyn 11
Lappeenranta 11
Las Vegas 11
Newark 11
Venice 11
West Jordan 11
Biên Hòa 10
Cape Town 10
Charlotte 10
Cotonou 10
Figino 10
Totale 13.914
Nome #
Biotransformation of Chloroaromatics: the Impact of Bioavailability and Substrate Specificity. 397
Structure and function of Aspergillus niger laccase McoG 324
2-Benzylpiperazine: a new scaffold for potent human Carbonic Anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents. 300
Crystal structure of a blue laccase from Lentinus tigrinus: evidences for intermediates in the molecular oxygen reductive splitting by multicopper oxidases. 298
Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae 279
1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: Potency is supported by X-ray crystallography of two leads 273
4-Arylbenzenesulfonamides as Human Carbonic Anhydrase Inhibitors (hCAIs): Synthesis by Pd Nanocatalyst-Mediated Suzuki-Miyaura Reaction, Enzyme Inhibition, and X-ray Crystallographic Studies 258
Determinants for Tight and Selective Binding of a Medicinal Dicarbene Gold(I) Complex to a Telomeric DNA G-Quadruplex: a Joint ESI MS and XRD Investigation 252
(1,3-Dioxolane)- and (1,3-oxathiolane)-2-pyrrolidines: molecular hybrids with potential anti-Alzheimer activity 242
Catechol 1,2-dioxygenase from the Gram-positive Rhodococcus opacus 1CP: Quantitative structure/activity relationship and the crystal structures of native enzyme and catechols adducts 233
Antagonisti muscarinici a struttura 1,3-ossatiolano-2-pirrolidinica 230
Chalcogenides-incorporating carbonic anhydrase inhibitors concomitantly reverted oxaliplatin-induced neuropathy and enhanced antiproliferative action 224
Role of the Benzodioxole Group in the Interactions between the Natural Alkaloids Chelerythrine and Coptisine and the Human Telomeric G-Quadruplex DNA. A Multiapproach Investigation 223
Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX 223
[Au(9-methylcaffein-8-ylidene)2]+/DNA Tel23 System: Solution, Computational, and Biological Studies 218
Crystal structure of the blue multicopper oxidase from the white-rot fungus Trametes trogii complexed with p-toluate 216
SYNTHESIS, AFFINITY PROFILE AND FUNCTIONAL ACTIVITY OF MUSCARINIC ANTAGONISTS WITH A 1-METHYL-2-(2,2-ALKYLARYL-1,3-OXATHIOLAN-5-YL)PYRROLIDINE STRUCTURE 216
Cristallographic studies of reduced Cu(I)-Zn(II) bovine superoxide dismutase and its adducts with small inorganic anions 215
Benzenesulfonamides Incorporating Flexible Triazole Moieties Are Highly Effective Carbonic Anhydrase Inhibitors: Synthesis and Kinetic, Crystallographic, Computational, and Intraocular Pressure Lowering Investigations 210
Crystallographic Determination of Reduced Bovine Superoxide-Dismutase at pH-5.0 and of Anion-Binding to its Active-Site 209
Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells 208
A BIOLOGICALLY ACTIVE GOLD COMPLEX: TRICHLORO[(2-PYRIDYL) METHANOL-N]GOLD(III) 204
X-ray structures of 4-chlorocatechol 1,2-dioxygenase adducts with substituted catechols: New perspectives in the molecular basis of intradiol ring cleaving dioxygenases specificity. 202
Synthesis and Cholinergic Affinity of Diastereomeric and Enantiomeric Isomers of 1-Methyl-2-(2-methyl-1,3-dioxolan-4-yl)-pyrrolidine, 1-Methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine and of Their Iodomethylates 199
Mechanisms of the Antiproliferative and Antitumor Activity of Novel Telomerase-Carbonic Anhydrase Dual-Hybrid Inhibitors 198
Crystal structure of a zinc-activated variant of Human Carbonic Anhydrase I, CA I Michigan 1: evidence for a second zinc binding site involving arginine coordination 197
Direct and Straightforward access to substituted alkyl selenols as novel carbonic anhydrase inhibitors 196
Salicylate 1,2-dioxygenase from Pseudaminobacter salicylatoxidans: crystal structure of a peculiar ring-cleaving dioxygenase. 196
The generation of a 1-hydroxy-2-naphthoate 1,2-dioxygenase by single point mutations of salicylate 1,2-dioxygenase – Rational design of mutants and the crystal structures of the A85H and W104Y variants 193
Diphenylcyclohexylamine derivatives as new potent multidrug resistance (MDR) modulators 190
Muscarinic antagonists with multiple stereocenters: synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives 186
Solution and Solid-State Analysis of Binding of 13-Substituted Berberine Analogues to Human Telomeric G-quadruplexes 185
Crystallization and preliminary structure analysis of the blue laccase from the ligninolytic fungus Panus tigrinus. 184
Azidothymidine "clicked" into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors 184
Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups. 182
Crystal Structure Determination of a Salicylate 1,2-Dioxygenase from Pseudaminobacter salicylatoxidans 181
Crystal structure of 3-chlorocatechol 1,2-dioxygenase key enzyme of a new modified ortho-pathway from the Gram-positive Rhodococcus opacus 1CP grown on 2-chlorophenol. 180
The crystal structure of human telomeric DNA complexed with berberine: an interesting case of stacked ligand to G-tetrad ratio higher than 1:1 180
Benzenesulfonamide decorated dihydropyrimidin(thi)ones: carbonic anhydrase profiling and antiproliferative activity 179
Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors 179
Crystal structure of 4-chlorocatechol 1,2-dioxygenase from the chlorophenol-utilizing gram-positive Rhodococcus opacus 1CP 175
The salicylate 1,2-dioxygenase as a model for a conventional gentisate 1,2-dioxygenase: crystal structures of the G106A mutant and its adducts with gentisate and salicylate. 173
Synthesis of different thio-scaffolds bearing sulfonamide with subnanomolar carbonic anhydrase II and IX inhibitory properties and X-ray investigations for their inhibitory mechanism 173
4-Chlorocatechol 1,2-dioxygenase fromthe chlorophenol-utilizing Gram-positive Rhodococcus opacus1CP: crystallization and preliminary crystallographic analysis. 171
Polypharmacology of epacadostat: A potent and selective inhibitor of the tumor associated carbonic anhydrases IX and XII 170
X-ray diffraction analyses of the natural isoquinoline alkaloids Berberine and Sanguinarine in complex with double helix DNA d(CGTACG) 167
Reaction Intermediates and Redox State Changes in a Blue Laccase from Steccherinum ochraceum observed by Crystallographic High/Low X-Ray Dose Experiments 166
Discovery of new 2, 5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity 166
Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies. 164
X-ray crystallographic and molecular docking studies on a unique chloromuconolactone dehalogenase from Rhodococcus opacus 1CP. 164
Calixarenes Incorporating Sulfonamide Moieties: Versatile Ligands for Carbonic Anhydrases Inhibition 163
Study of Chalcogen Aspirin Derivatives with Carbonic Anhydrase Inhibitory Properties for Treating Inflammatory Pain 162
Anion inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae 162
Synthesis of Azasugar–Sulfonamide conjugates and their Evaluation as Inhibitors of Carbonic Anhydrases: the Azasugar Approach to Selectivity 162
Selenols: a new class of carbonic anhydrase inhibitors 161
One-Pot Procedure for the Synthesis of Asymmetric Substituted Ureido Benzene Sulfonamides as Effective Inhibitors of Carbonic Anhydrase Enzymes 161
Benzoselenoates: A novel class of carbonic anhydrase inhibitors 160
Hydroxyquinol 1,2-dioxygenase 158
Preliminary Crystallographic Analysis of 3-Chlorocatechol 1,2-Dioxygenase of a New Modified Ortho-pathway from the Gram-Positive Rhodococcus opacus 1CP Grown on 2-Chlorophenol. 158
Interaction of a gold(i) dicarbene anticancer drug with human telomeric DNA G-quadruplex: solution and computationally aided X-ray diffraction analysis 158
Preliminary crystallographic analysis of salicylate 1,2-dioxygenase from Pseudaminobacter salicylatoxidans. 156
Crystal analysis of aromatic sulfonamide binding to native and (Zn)2 adduct of human carbonic anhydrase I Michigan 1. 155
Crystal analysis of Aromatic sulfonamide binding to native and (Zn)2adduct to Human Carbonic Anhydrase I Michigan 1 152
The Crystal structure of the Monomeric Human SOD Mutant F50E/G51E/E133Q at Atomic Resolution. The Enzyme mechanism Revisited 152
Function of different amino acid residues in the reaction mechanism of gentisate 1,2-dioxygenases deduced from the analysis of mutants of the salicylate 1,2-dioxygenase from Pseudaminobacter salicylatoxidans 152
Structure determination of a blue laccase from Trametes Trogii at 1.5 Å 151
Crystal structures of salicylate 1,2-dioxygenase-substrates adducts: A step towards the comprehension of the structural basis for substrate selection in class III ring cleaving dioxygenases 150
Fluorescent sulfonamide carbonic anhydrase inhibitors incorporating 1,2,3-triazole moieties: Kinetic and X-ray crystallographic studies 148
Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins 147
Polymeric hydrophobic membranes as a tool to control polymorphism and protein–ligand interactions 146
Laccase isoforms with unusual properties from the basidiomycete Steccherinum ochraceum strain 1833 146
Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy 146
Chlorocatechol 1, 2-dioxygenase from the Chlorophenol-utilizing Gram-positive Rhodococcus opacus 1CP: Crystallization and preliminary crystallographic analysis 143
Pyridine Derivative of the Natural Alkaloid Berberine as Human Telomeric G4-DNA Binder: A Solution and Solid-State Study 142
A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments 139
Lasamide, a Potent Human Carbonic Anhydrase Inhibitor from the Market: Inhibition Profiling and Crystallographic Studies 139
Dioxygen, an unexpected carbonic anhydrase ligand 139
The crystal structures of native hydroquinone 1,2-dioxygenase from Sphingomonas sp. TTNP3 and of substrate and inhibitor complexes 139
X-ray crystallographic and kinetic studies of biguanide containing aryl sulfonamides as carbonic anhydrase inhibitors 136
Thia- and Seleno-Michael Reactions for the Synthesis of Carbonic Anhydrases Inhibitors 135
Crystal structure of the hydroxyquinol 1,2-dioxygenase from Nocardioides simplex 3E, a key enzyme involved in polychlorinated aromatics biodegradation 135
Molecular Basis of Pseudomonas syringae pv actinidiae Levansucrase Inhibition by a Multivalent Iminosugar 134
Mono- and three-tailed sugar and iminosugar decorated benzenesulfonamide carbonic anhydrase inhibitors 134
Crystal structure and chemical inhibition of essential schistosome host-interactive virulence factor carbonic anhydrase SmCA 134
Selenolesterase enzyme activity of carbonic anhydrases 134
Selenocarbamates As a Prodrug-Based Approach to Carbonic Anhydrase Inhibition 133
Crystallization and preliminary X-ray crystallographic analysis of the small subunit of the heterodimeric laccase POXA3b from Pleurotus ostreatus. 133
X-ray structural study of human neutrophil elastase inhibition with a series of azaindoles, azaindazoles and isoxazolones 131
Structural basis for the substrate specificity and the absence of dehalogenation activity in 2-chloromuconate cycloisomerase from Rhodococcus opacus 1CP 131
Diversely N-substituted benzenesulfonamides dissimilarly bind to human carbonic anhydrases: crystallographic investigations of N-nitrosulfonamides 130
Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: Solution and X-ray crystallographic studies 130
Famotidine, an Antiulcer Agent, Strongly Inhibits Helicobacter pylori and Human Carbonic Anhydrases 129
Interaction of Carboxypeptidase A with Anions: Crystal Structure of the Complex with the HPO42- Anion 129
Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae 128
Structural basis of hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase 128
Inhibition of Pseudomonas aeruginosa Carbonic Anhydrases, Exploring Ciprofloxacin Functionalization Toward New Antibacterial Agents: An In-Depth Multidisciplinary Study 127
Synthetic Approaches to Novel Human Carbonic Anhydrase Isoform Inhibitors Based on Pyrrol-2-one Moiety 127
First-in-Class Dual Targeting Compounds for the Management of Seizures in Glucose Transporter Type 1 Deficiency Syndrome 127
Double helices forming unusual binding motifs: the case of the natural alkaloids coptisine and chelerythrine 126
Design, synthesis, biological evaluation and crystal structure determination of dual modulators of carbonic anhydrases and estrogen receptors 125
Totale 17.655
Categoria #
all - tutte 58.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.955


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022515 0 0 0 22 21 39 37 49 40 28 108 171
2022/20231.692 191 352 53 100 128 288 197 83 203 9 51 37
2023/2024606 28 59 119 39 54 81 7 110 14 41 37 17
2024/20254.993 128 484 309 706 1.519 798 113 260 197 101 166 212
2025/20267.023 565 923 710 656 626 254 711 372 531 467 308 900
2026/20271.594 289 286 588 431 0 0 0 0 0 0 0 0
Totale 20.968